Is COVID-19 improving pharma’s reputation?

A new Takeda study conducted by Ipsos MORI in the U.K. finds consumers and healthcare providers favor pharma companies with a clear sense of purpose. Thinking pharma might earn a reputation halo with its COVID-19 work? Not so fast, Takeda says. Its recent U.K. study finds only an incremental boost in positive consumer sentiment. [...]

Latin America: How pharma can navigate a complex market

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. There are a number of companies that, even in the last decade, have left the Latin American market completely because they just couldn’t [...]

Pharma Marketing: forget influencers, stick to patient connections

More community trust. Less forced connections. A recent UK survey found that only 14% percent of users mostly or completely trust lifestyle influencers, while 51% completely or mostly trust patient influencers. When it comes to branded pharma products, the survey was even more positive for patient influencers: 85% said they would be very or [...]